Hybrid closed loop system seen as step toward artificial pancreas
Technology described as a step towards an artificial pancreas could be offered to people in England and Wales who are struggling to manage their type 1 diabetes.
In draft guidance, an independent NICE (National Institute for Health Care Excellence) committee has recommended the use of hybrid closed loop systems for managing blood glucose levels in type 1 diabetes.
NHS trials have provided the data which has allowed NICE to consider wider use of the technology which allows a person with type 1 diabetes to go about their day-to-day life without having to monitor their blood glucose levels.
In a statement, Mark Chapman, interim director of Medical Technology at NICE, said: “Some people living with type 1 diabetes struggle to manage their condition, even though they are doing everything asked of them by their diabetes team. This technology is the best intervention to help them control their diabetes, barring a cure.”
If type 1 diabetes is not well controlled, people are at risk of long-term complications of hyperglycaemia, including blindness, amputations, or kidney problems.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
The EU and UK will be moving towards using Grid Forming inverters with Energy Storage that has an inherent ability to act as a source of Infinite...